Arabian International Healthcare Holding Company (TADAWUL:9530)
20.04
0.00 (0.00%)
Apr 29, 2026, 12:22 PM AST
TADAWUL:9530 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 842.21 | 739.28 | 806.92 | 642.67 | 618.54 | Upgrade
|
| Revenue Growth (YoY) | 13.92% | -8.38% | 25.56% | 3.90% | -24.45% | Upgrade
|
| Cost of Revenue | 647.45 | 566.99 | 616.89 | 488.51 | 475.02 | Upgrade
|
| Gross Profit | 194.77 | 172.29 | 190.04 | 154.16 | 143.52 | Upgrade
|
| Selling, General & Admin | 129.28 | 118.34 | 136.79 | 113.62 | 90.96 | Upgrade
|
| Other Operating Expenses | -9.99 | -13.64 | -13.1 | -9.56 | -11 | Upgrade
|
| Operating Expenses | 119.11 | 122.23 | 130.21 | 100.58 | 62.42 | Upgrade
|
| Operating Income | 75.66 | 50.06 | 59.82 | 53.58 | 81.09 | Upgrade
|
| Interest Expense | -29.14 | -38.17 | -36.16 | -18.51 | -13 | Upgrade
|
| Interest & Investment Income | 1.83 | 2.14 | 5.1 | 0.72 | - | Upgrade
|
| Earnings From Equity Investments | -1.54 | -5.76 | -2.04 | 7.79 | 11.5 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.07 | -0.94 | -0.52 | -0.81 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.98 | -2.35 | -0.4 | -0.05 | -0.37 | Upgrade
|
| EBT Excluding Unusual Items | 38.76 | 4.98 | 25.8 | 42.71 | 79.11 | Upgrade
|
| Impairment of Goodwill | - | -93.66 | -17.2 | - | - | Upgrade
|
| Other Unusual Items | - | 34.16 | 45.32 | -6.12 | 14.63 | Upgrade
|
| Pretax Income | 38.76 | -54.52 | 53.92 | 36.59 | 93.74 | Upgrade
|
| Income Tax Expense | 10.17 | 7.81 | 11.57 | 10.89 | 11.42 | Upgrade
|
| Earnings From Continuing Operations | 28.59 | -62.33 | 42.35 | 25.71 | 82.31 | Upgrade
|
| Earnings From Discontinued Operations | -9.6 | -8.41 | - | - | - | Upgrade
|
| Net Income to Company | 18.99 | -70.73 | 42.35 | 25.71 | 82.31 | Upgrade
|
| Minority Interest in Earnings | 4.61 | 4.12 | -4.26 | -5.23 | - | Upgrade
|
| Net Income | 23.6 | -66.61 | 38.09 | 20.47 | 82.31 | Upgrade
|
| Net Income to Common | 23.6 | -66.61 | 38.09 | 20.47 | 82.31 | Upgrade
|
| Net Income Growth | - | - | 86.03% | -75.13% | -14.07% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | - | - | -0.94% | -0.11% | 1430.22% | Upgrade
|
| EPS (Basic) | 1.19 | -3.37 | 1.92 | 1.02 | 4.12 | Upgrade
|
| EPS (Diluted) | 1.19 | -3.37 | 1.92 | 1.02 | 4.12 | Upgrade
|
| EPS Growth | - | - | 87.80% | -75.10% | -94.38% | Upgrade
|
| Free Cash Flow | -2.07 | 102.28 | 4.21 | 57.49 | 129.11 | Upgrade
|
| Free Cash Flow Per Share | -0.10 | 5.17 | 0.21 | 2.88 | 6.46 | Upgrade
|
| Dividend Per Share | - | - | - | 1.000 | 3.000 | Upgrade
|
| Dividend Growth | - | - | - | -66.67% | -26.83% | Upgrade
|
| Gross Margin | 23.13% | 23.30% | 23.55% | 23.99% | 23.20% | Upgrade
|
| Operating Margin | 8.98% | 6.77% | 7.41% | 8.34% | 13.11% | Upgrade
|
| Profit Margin | 2.80% | -9.01% | 4.72% | 3.19% | 13.31% | Upgrade
|
| Free Cash Flow Margin | -0.25% | 13.84% | 0.52% | 8.95% | 20.87% | Upgrade
|
| EBITDA | 85.83 | 60.92 | 68.91 | 58.57 | 84.74 | Upgrade
|
| EBITDA Margin | 10.19% | 8.24% | 8.54% | 9.11% | 13.70% | Upgrade
|
| D&A For EBITDA | 10.18 | 10.86 | 9.08 | 4.99 | 3.65 | Upgrade
|
| EBIT | 75.66 | 50.06 | 59.82 | 53.58 | 81.09 | Upgrade
|
| EBIT Margin | 8.98% | 6.77% | 7.41% | 8.34% | 13.11% | Upgrade
|
| Effective Tax Rate | 26.24% | - | 21.46% | 29.75% | 12.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.